NCT05557422 - BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System. | Biotech Hunter

Enrollment

322

Participants

Timeline

Start Date

October 12, 2022

Primary Completion Date

May 8, 2024

Study Completion Date

May 8, 2024

Conditions

Chronic Lymphoproliferative Diseases (CLPD)

Interventions

DIAGNOSTIC_TEST

BD OneFlow LST, and B-CLPD T1 to T4 Assays

a panel of fluorochrome-conjugated antibodies for qualitative flow-cytometric immunophenotyping of mature lymphocyte populations on the BD FACSLyric™ flow cytometer with BD FACSuite™ Clinical application.

Trial Locations (6)

27514

University of Norht Calolina, Chapel Hill

78256

CorePATH Laboratories, San Antonio

3015 GD

Erasmus Medical Center, Laboratory Medical Immunology, Department of Immunology, Rotterdam

Unknown

Champalimaud Foundation, Lisbon

University of Salamanca, Salamanca

Kantonsspital Aarau AG / IfLM, Aarau